Suppr超能文献

埃博拉病毒 VP35 是一种多功能毒力因子。

Ebolavirus VP35 is a multifunctional virulence factor.

机构信息

Department of Biochemistry, Biophysics and Molecular Biology, Iowa State University, Ames, IA, USA.

出版信息

Virulence. 2010 Nov-Dec;1(6):526-31. doi: 10.4161/viru.1.6.12984. Epub 2010 Nov 1.

Abstract

Ebola virus (EBOV) is a member of the filoviridae family that causes severe hemorrhagic fever during sporadic outbreaks, and no approved treatments are currently available. The multifunctional EBOV VP35 protein facilitates immune evasion by antagonizing antiviral signaling pathways and is important for viral RNA synthesis. In order to elucidate regulatory mechanisms and to develop countermeasures, we recently solved the structures of the Zaire and Reston EBOV VP35 interferon inhibitory domain (IID) in the free form and of the Zaire EBOV VP35 IID bound to dsRNA. Together with biochemical, cell biological, and virological studies, our structural work revealed that distinct regions within EBOV VP35 IID contribute to virulence through host immune evasion and viral RNA synthesis. Here we summarize our recent structural and functional studies and discuss the potential of multifunctional Ebola VP35 as a therapeutic target.

摘要

埃博拉病毒(EBOV)是丝状病毒科的一员,在零星爆发期间会引起严重的出血热,目前尚无批准的治疗方法。多功能的 EBOV VP35 蛋白通过拮抗抗病毒信号通路来促进免疫逃逸,并且对病毒 RNA 合成很重要。为了阐明调控机制并开发对策,我们最近解析了扎伊尔和雷斯顿 EBOV VP35 干扰素抑制结构域(IID)在游离形式和与 dsRNA 结合的扎伊尔 EBOV VP35 IID 的结构。结合生化、细胞生物学和病毒学研究,我们的结构工作表明,EBOV VP35 IID 内的不同区域通过宿主免疫逃逸和病毒 RNA 合成来促进毒力。在这里,我们总结了我们最近的结构和功能研究,并讨论了多功能埃博拉病毒 VP35 作为治疗靶点的潜力。

相似文献

1
Ebolavirus VP35 is a multifunctional virulence factor.
Virulence. 2010 Nov-Dec;1(6):526-31. doi: 10.4161/viru.1.6.12984. Epub 2010 Nov 1.
2
Structure of the Ebola VP35 interferon inhibitory domain.
Proc Natl Acad Sci U S A. 2009 Jan 13;106(2):411-6. doi: 10.1073/pnas.0807854106. Epub 2009 Jan 2.
3
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells.
J Virol. 2015 Aug;89(15):7567-83. doi: 10.1128/JVI.00924-15. Epub 2015 May 13.
5
Serological reactivity of baculovirus-expressed Ebola virus VP35 and nucleoproteins.
Microbes Infect. 2003 Apr;5(5):379-85. doi: 10.1016/s1286-4579(03)00051-0.
6
Insights into the homo-oligomerization properties of N-terminal coiled-coil domain of Ebola virus VP35 protein.
Virus Res. 2018 Mar 2;247:61-70. doi: 10.1016/j.virusres.2018.02.003. Epub 2018 Feb 7.
8
Expression, purification, crystallization and preliminary X-ray studies of the Ebola VP35 interferon inhibitory domain.
Acta Crystallogr Sect F Struct Biol Cryst Commun. 2009 Feb 1;65(Pt 2):163-5. doi: 10.1107/S1744309108044187. Epub 2009 Jan 31.
9
Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.
Nat Struct Mol Biol. 2010 Feb;17(2):165-72. doi: 10.1038/nsmb.1765. Epub 2010 Jan 17.
10
Development of RNA aptamers targeting Ebola virus VP35.
Biochemistry. 2013 Nov 26;52(47):8406-19. doi: 10.1021/bi400704d. Epub 2013 Nov 14.

引用本文的文献

1
The Plethora of RNA-Protein Interactions Model a Basis for RNA Therapies.
Genes (Basel). 2025 Jan 2;16(1):48. doi: 10.3390/genes16010048.
2
Aptamers: precision tools for diagnosing and treating infectious diseases.
Front Cell Infect Microbiol. 2024 Sep 25;14:1402932. doi: 10.3389/fcimb.2024.1402932. eCollection 2024.
4
Pathogenicity and Virulence of Ebolaviruses with Species- and Variant-specificity.
Virulence. 2021 Dec;12(1):885-901. doi: 10.1080/21505594.2021.1898169.
8
Relevance of Ebola virus VP35 homo-dimerization on the type I interferon cascade inhibition.
Antivir Chem Chemother. 2019 Jan-Dec;27:2040206619889220. doi: 10.1177/2040206619889220.
9
Ebola Virus Replication Stands Out.
Trends Microbiol. 2019 Jul;27(7):565-566. doi: 10.1016/j.tim.2019.05.004. Epub 2019 May 30.
10
Ebola virus VP35 has novel NTPase and helicase-like activities.
Nucleic Acids Res. 2019 Jun 20;47(11):5837-5851. doi: 10.1093/nar/gkz340.

本文引用的文献

1
Basic residues within the ebolavirus VP35 protein are required for its viral polymerase cofactor function.
J Virol. 2010 Oct;84(20):10581-91. doi: 10.1128/JVI.00925-10. Epub 2010 Aug 4.
3
The chase for the RIG-I ligand--recent advances.
Mol Ther. 2010 Jul;18(7):1254-62. doi: 10.1038/mt.2010.90. Epub 2010 May 11.
4
Structural and functional characterization of Reston Ebola virus VP35 interferon inhibitory domain.
J Mol Biol. 2010 Jun 11;399(3):347-57. doi: 10.1016/j.jmb.2010.04.022. Epub 2010 Apr 24.
5
Structural basis for dsRNA recognition and interferon antagonism by Ebola VP35.
Nat Struct Mol Biol. 2010 Feb;17(2):165-72. doi: 10.1038/nsmb.1765. Epub 2010 Jan 17.
6
Mutations abrogating VP35 interaction with double-stranded RNA render Ebola virus avirulent in guinea pigs.
J Virol. 2010 Mar;84(6):3004-15. doi: 10.1128/JVI.02459-09. Epub 2010 Jan 13.
7
Recognition of viruses by cytoplasmic sensors.
Curr Opin Immunol. 2010 Feb;22(1):41-7. doi: 10.1016/j.coi.2009.12.003. Epub 2010 Jan 12.
8
Ebolavirus VP35 uses a bimodal strategy to bind dsRNA for innate immune suppression.
Proc Natl Acad Sci U S A. 2010 Jan 5;107(1):314-9. doi: 10.1073/pnas.0910547107. Epub 2009 Dec 14.
9
Evasion of interferon responses by Ebola and Marburg viruses.
J Interferon Cytokine Res. 2009 Sep;29(9):511-20. doi: 10.1089/jir.2009.0076.
10
Ebola Zaire virus blocks type I interferon production by exploiting the host SUMO modification machinery.
PLoS Pathog. 2009 Jun;5(6):e1000493. doi: 10.1371/journal.ppat.1000493. Epub 2009 Jun 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验